We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$13.8B
AUM Growth
-$581M
Cap. Flow
-$2.79B
Cap. Flow %
-20.16%
Top 10 Hldgs %
25.18%
Holding
905
New
29
Increased
148
Reduced
448
Closed
194

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$66.4M
2
VLO icon
Valero Energy
VLO
+$28.9M
3
SLB icon
SLB Ltd
SLB
+$24.8M
4
BNY
Bank of New York Mellon
BNY
+$22.6M
5
PEP icon
PepsiCo
PEP
+$20.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$182M
2
AAPL icon
Apple
AAPL
+$148M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.9M
4
AMGN icon
Amgen
AMGN
+$72.1M
5
TSLA icon
Tesla
TSLA
+$66.1M

Sector Composition

Rank Sector Weight
1 Healthcare 31.26%
2 Technology 28.78%
3 Financials 8.15%
4 Consumer Discretionary 7.54%
5 Industrials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYTK icon
176
Cytokinetics
CYTK
$11B
$17.6M 0.13%
538,240
– –
FSLR icon
177
First Solar
FSLR
$21.8B
$17.2M 0.12%
90,671
+17,156
+23% +$3.4M
INSM icon
178
Insmed
INSM
$23.2B
$17M 0.12%
807,200
-189,892
-19% -$3.6M
PNC icon
179
PNC Financial Services
PNC
$100B
$16.9M 0.12%
133,933
-66,063
-33% -$8.07M
ALB icon
180
Albemarle
ALB
$13.5B
$16.8M 0.12%
75,243
-10,728
-12% -$2.19M
DFS
181
DELISTED
Discover Financial Services
DFS
$16.4M 0.12%
140,090
-19,907
-12% -$2.09M
XNCR icon
182
Xencor
XNCR
$1.44B
$16.3M 0.12%
652,984
-45,435
-7% -$1.24M
CHD icon
183
Church & Dwight Co
CHD
$23.1B
$16.3M 0.12%
162,182
-189,978
-54% -$17.9M
TD icon
184
Toronto Dominion Bank
TD
$198B
$16.2M 0.12%
260,503
-142,457
-35% -$8.57M
MAR icon
185
Marriott International
MAR
$98.7B
$16.1M 0.12%
87,737
-129,687
-60% -$22.5M
LEGN icon
186
Legend Biotech
LEGN
$4.3B
$15.9M 0.12%
231,032
+115,006
+99% +$7.51M
XYL icon
187
Xylem
XYL
$28.5B
$15.8M 0.11%
139,881
-77,552
-36% -$8.2M
HCA icon
188
HCA Healthcare
HCA
$84.8B
$15.6M 0.11%
51,462
-44,614
-46% -$12.4M
EQR icon
189
Equity Residential
EQR
$25.4B
$15.6M 0.11%
236,680
-63,899
-21% -$3.99M
WAB icon
190
Wabtec
WAB
$51.1B
$15.6M 0.11%
142,187
+6,009
+4% +$597K
RVMD icon
191
Revolution Medicines
RVMD
$40.2B
$15.5M 0.11%
579,948
-26,384
-4% -$647K
BNTX icon
192
BioNTech
BNTX
$22.6B
$15.4M 0.11%
142,303
-10,080
-7% -$1.13M
VCYT icon
193
Veracyte
VCYT
$4.52B
$15.3M 0.11%
600,926
-21,220
-3% -$514K
ACGL icon
194
Arch Capital
ACGL
$36.1B
$15.2M 0.11%
202,837
-234,269
-54% -$16.9M
BAP icon
195
Credicorp
BAP
$30.9B
$15M 0.11%
101,900
-2,700
-3% -$371K
NTRA icon
196
Natera
NTRA
$37.5B
$14.8M 0.11%
305,014
+180,851
+146% +$9.23M
KRTX
197
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$14.6M 0.11%
67,201
– –
BMO icon
198
Bank of Montreal
BMO
$125B
$14.5M 0.11%
160,732
-87,055
-35% -$7.7M
BKNG icon
199
Booking.com
BKNG
$138B
$14.5M 0.1%
134,350
+18,650
+16% +$1.97M
MORF
200
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$14.3M 0.1%
249,933
-40,000
-14% -$2.09M
6 7
8
9 10

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2023 Portfolio in Review

As of Q2 2023, Candriam SCA held 905 positions worth $13.8B, down 4% from $14.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Candriam SCA withdrew a net $2.79B in Q2 2023, closing 194 positions and reducing 448 holdings. Its most notable exit was Thomson Reuters, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Vir Biotechnology worth $8.7M.

  • Candriam SCA's largest Q2 2023 buy was Vir Biotechnology: 354,645 shares worth $8.7M.
  • Candriam SCA added most to Lam Research in Q2 2023, an estimated $66.4M increase.
  • Candriam SCA's biggest Q2 2023 reduction was Microsoft, cutting an estimated $182M.
  • Candriam SCA fully exited Thomson Reuters in Q2 2023, selling an estimated $19.8M.
  • Candriam SCA's ten largest holdings make up 25% of its $13.8B portfolio in Q2 2023.
  • Candriam SCA opened 29 new positions and closed 194 in Q2 2023.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $13.8B.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.